Amanote Research

Amanote Research

    RegisterSign In

Editorial: Mesalazine and Mucosal Microbiome in Quiescent Ulcerative Colitis-What Can We Learn?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15281
Full Text
Open PDF
Abstract

Available in full text

Categories
HepatologyPharmacologyGastroenterology
Date

May 27, 2019

Authors
Anna M. BuchnerGary R. Lichtenstein
Publisher

Wiley


Related search

Editorial: Mesalamine and Mucosal Microbiome in Quiescent Ulcerative Colitis-What Can We Learn? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Systematic Review: Safety of Mesalazine in Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

What Can We Learn From Liver?

2016English

Confidentiality in Mediation - What Can We Learn ?

2018English

What Can We Learn About Wellbeing in School?

The Journal of Student Wellbeing
2011English

What Can We Learn From Bobtail Squid?

2019English

What Can We Learn From Numerical Data?

Cardiology in the Young
PediatricsCardiologyPerinatologyCardiovascular MedicineMedicineChild Health
2000English

Ileal and Colonic Epithelial Metabolism in Quiescent Ulcerative Colitis.

Gut
Gastroenterology
1994English

Gut Mucosal Virome Alterations in Ulcerative Colitis

Gut
Gastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy